Illexcor Therapeutics
Henrico, US · Founded 2026 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
TE
Timothy E LadinExecutive
AN
Andrew N FleischmanExecutive
Board
MM
Maneka MirchandaneyBoard director
GM
TL
Ted LoveBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$13M disclosed across 1 round · 2026
▶$13MraisedMay 2026 · 6 investors · BiotechnologyRule 506(b)
▶$13MraisedMay 2026 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy E LadinExecutive Officer
- Andrew N FleischmanExecutive Officer, Director
- Maneka MirchandaneyDirector
- Giovanni MariggiDirector
- Ted LoveDirector
- Offering amount
- $69M
- Amount sold
- $13M
- Minimum investment
- $1M
- Proceeds to insiders
- $800K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Illexcor Therapeutics's investors?
- Illexcor Therapeutics's investors include Medicxi.
- How much funding has Illexcor Therapeutics raised?
- Illexcor Therapeutics has disclosed $13M raised across 1 round.
- Where is Illexcor Therapeutics headquartered?
- Illexcor Therapeutics is headquartered in Henrico, US.